Literature DB >> 7562927

Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate.

I Lefebvre1, C Périgaud, A Pompon, A M Aubertin, J L Girardet, A Kirn, G Gosselin, J L Imbach.   

Abstract

The synthesis, in vitro anti-HIV-1 activity, and decomposition pathways of several mononucleoside phosphotriester derivatives of 3'-azido-2',3'-dideoxythymidine (AZT) incorporating a new kind of carboxylate esterase-labile transient phosphate-protecting group, namely, S-acyl-2-thioethyl, are reported. All the described compounds showed marked antiviral activity in thymidine kinase-deficient CEM cells in which AZT was virtually inactive. The results strongly support the hypothesis that such pronucleotides exert their biological effects via intracellular delivery of the 5'-mononucleotide of AZT. This point was corroborated by decomposition studies in cell extracts and culture medium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562927     DOI: 10.1021/jm00020a007

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  Metabolic labeling enables selective photocrosslinking of O-GlcNAc-modified proteins to their binding partners.

Authors:  Seok-Ho Yu; Michael Boyce; Amberlyn M Wands; Michelle R Bond; Carolyn R Bertozzi; Jennifer J Kohler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

2.  Synthesis and Conjugation of Small Interfering Ribonucleic Neutral SiRNNs.

Authors:  Alexander S Hamil; Steven F Dowdy
Journal:  Methods Mol Biol       Date:  2016

3.  Enzymatic and cellular study of a serotonin N-acetyltransferase phosphopantetheine-based prodrug.

Authors:  Yousang Hwang; Surajit Ganguly; Anthony K Ho; David C Klein; Philip A Cole
Journal:  Bioorg Med Chem       Date:  2006-12-13       Impact factor: 3.641

Review 4.  Synthesis of nucleoside phosphate and phosphonate prodrugs.

Authors:  Ugo Pradere; Ethel C Garnier-Amblard; Steven J Coats; Franck Amblard; Raymond F Schinazi
Journal:  Chem Rev       Date:  2014-08-21       Impact factor: 60.622

5.  Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications.

Authors:  Bryan R Meade; Khirud Gogoi; Alexander S Hamil; Caroline Palm-Apergi; Arjen van den Berg; Jonathan C Hagopian; Aaron D Springer; Akiko Eguchi; Apollo D Kacsinta; Connor F Dowdy; Asaf Presente; Peter Lönn; Manuel Kaulich; Naohisa Yoshioka; Edwige Gros; Xian-Shu Cui; Steven F Dowdy
Journal:  Nat Biotechnol       Date:  2014-11-17       Impact factor: 54.908

6.  The pro-oligonucleotide approach: solid phase synthesis and preliminary evaluation of model pro-dodecathymidylates.

Authors:  G Tosquellas; K Alvarez; C Dell'Aquila; F Morvan; J J Vasseur; J L Imbach; B Rayner
Journal:  Nucleic Acids Res       Date:  1998-05-01       Impact factor: 16.971

7.  Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells.

Authors:  Joanne E Tomassini; Krista Getty; Mark W Stahlhut; Sung Shim; Balkrishen Bhat; Anne B Eldrup; Thazha P Prakash; Steven S Carroll; Osvaldo Flores; Malcolm MacCoss; Daniel R McMasters; Giovanni Migliaccio; David B Olsen
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

8.  An efficient biodelivery system for antisense polyamide nucleic acid (PNA).

Authors:  Mohamed Mehiri; Gregory Upert; Snehlata Tripathi; Audrey Di Giorgio; Roger Condom; Virendra N Pandey; Nadia Patino
Journal:  Oligonucleotides       Date:  2008-09

Review 9.  Prospects for antisense peptide nucleic acid (PNA) therapies for HIV.

Authors:  Virendra N Pandey; Alok Upadhyay; Binay Chaubey
Journal:  Expert Opin Biol Ther       Date:  2009-08       Impact factor: 4.388

10.  Probing phospholipase a(2) with fluorescent phospholipid substrates.

Authors:  Oliver Wichmann; Michael H Gelb; Carsten Schultz
Journal:  Chembiochem       Date:  2007-09-03       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.